ABVC BioPharma, Inc. Increase (Decrease) in Security Deposits
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Security Deposits of $31.17 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2026-08-12
- ABVC BioPharma, Inc. increase (decrease) in security deposits for the quarter ending 2026-06-30 was $22.09K, a 12.24% increase year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in security deposits for the quarter ending 2026-03-31 was $9.08K, a 80.49% increase year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in security deposits for the quarter ending 2025-12-31 was -$12.00K.
- ABVC BioPharma, Inc. increase (decrease) in security deposits for the quarter ending 2025-09-30 was -$29.57K.
- ABVC BioPharma, Inc. increase (decrease) in security deposits for fiscal 2025 was -$16.86K.
- ABVC BioPharma, Inc. increase (decrease) in security deposits for fiscal 2023 was $13.70K.
- ABVC BioPharma, Inc. increase (decrease) in security deposits for fiscal 2022 was -$2.60K.
- ABVC BioPharma, Inc. increase (decrease) in security deposits for fiscal 2021 was -$357.28K.
| Period end | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 9 month | Increase (Decrease) in Security Deposits 12 month | Increase (Decrease) in Security Deposits 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $22.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $31.17K 10-Q · filed 2026-08-12 | $19.17K derived: sum of 3 quarters · filed 2026-08-12 | -$10.41K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $9.08K 10-Q · filed 2026-05-18 | -$2.92K derived: sum of 2 quarters · filed 2026-05-18 | -$32.50K derived: sum of 3 quarters · filed 2026-05-18 | -$12.82K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$12.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | -$41.58K derived: sum of 2 quarters · filed 2026-03-03 | -$21.89K derived: sum of 3 quarters · filed 2026-08-12 | -$16.86K 10-K · filed 2026-03-03 | |
| 2025-09-30 | -$29.57K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | -$9.89K derived: sum of 2 quarters · filed 2026-08-12 | -$4.87K 10-Q/A · filed 2026-03-03 | ||
| 2025-06-30 | $19.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $24.71K 10-Q · filed 2026-08-12 | |||
| 2025-03-31 | $5.03K 10-Q · filed 2025-04-30 | ||||
| 2024-09-30 | -$2.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-03 | $4.00K 10-Q/A · filed 2026-03-03 | |||
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-13 | ||||
| 2023-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $16.00K derived: sum of 2 quarters · filed 2025-04-15 | $13.70K 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.30K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$2.30K 10-Q · filed 2024-08-14 | ||||
| 2022-12-31 | -$245.66K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$2.60K 10-K · filed 2024-03-13 | $238.09K 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $243.06K 10-Q · filed 2022-11-14 | ||||
| 2021-12-31 | $289.94K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$357.28K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | -$647.22K 10-Q · filed 2022-11-14 |